Back to 
BARCLAYS PLC
BARCLAYS PLC
EVLOShowing 0 of 3 quarters
Position history for BARCLAYS PLC's holdings in EVELO BIOSCIENCES INC
No. Barclays exited its EVLO (Evelo Biosciences) position in Q4 2023. Its Q3 2023 13F listed 11,755 shares worth $46,079. Barclays first reported EVLO in Q2 2023 and held it in 2 quarterly 13F filings.
Current Value
-
Current Shares
-
Total Value Change
$0
Total Shares Change
0
No position history available for this security.
Other major holders of EVLO: FMR LLC, Alyeska Investment Group, L.P., STATE OF MICHIGAN RETIREMENT SYSTEM